Long term outcomes of first and second generation drug-eluting stents in patients with diabetes: a pooled analysis of individual patient data from SORT OUT III, IV and V trials.
Four-year clinical outcome following randomised use of zotarolimus-eluting stents versus everolimus-eluting stents in all-comers: insights from the DUTCH PEERS trial